Kisho

Emergent Manufacturing Operations Baltimore, LLC — Rare Disease Pipeline | Kisho | Kisho

Emergent Manufacturing Operations Baltimore, LLC

Other

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
Ebola hemorrhagic fever	EBANGA™	Orphan Designation	-
cutaneous anthrax	RAXIBACUMAB	-	FDA Approved
gastrointestinal anthrax	RAXIBACUMAB	-	FDA Approved
infectious disease	EBANGA™	Orphan Designation	-
oropharyngeal anthrax	RAXIBACUMAB	-	FDA Approved
post-thrombotic syndrome	ansuvimab	Orphan Designation	-
post-traumatic stress disorder	ansuvimab	Orphan Designation	-
post-vaccinal encephalitis	ansuvimab	Orphan Designation	-